General Information of Drug (ID: DM4XPYJ)

Drug Name
Avicin D Drug Info
Synonyms Avicin D (cancer)
Cross-matching ID
PubChem CID
44566777
CAS Number
CAS 197787-20-5
TTD Drug ID
D0R5VO

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Insulin secretion -1.62 3.10e-2 75/86 (87.21%) CREB3;PCLO;ATP1A3;...
Fatty acid degradation -1.65 2.34e-2 40/43 (93.02%) ACAT1;EHHADH;HADH;...
Vibrio cholerae infection -1.66 1.90e-2 44/50 (88%) ACTB;ATP6AP1;KCNQ1;...
Carbohydrate digestion and absorption -1.66 1.97e-2 37/47 (78.72%) PLCB3;PRKCB;HK1;...
Protein processing in endoplasmic reticulum -1.67 1.92e-2 127/171 (74.27%) PREB;NGLY1;SEL1L;...
Starch and sucrose metabolism -1.68 1.68e-2 25/36 (69.44%) ENPP1;HK1;HK3;...
Metabolism of xenobiotics by cytochrome P450 -1.69 1.65e-2 49/77 (63.64%) EPHX1;CYP2C9;GSTM4;...
Thyroid hormone synthesis -1.71 1.38e-2 66/75 (88%) ATP1A3;PLCB2;ATF4;...
Citrate cycle (TCA cycle) -1.71 1.44e-2 30/30 (100%) CS;SUCLG1;PDHA1;...
Bacterial invasion of epithelial cells -1.72 1.40e-2 59/77 (76.62%) ARPC2;PIK3CA;ARPC1A;...
Biosynthesis of unsaturated fatty acids -1.72 1.42e-2 21/27 (77.78%) ACOT7;HACD2;HACD3;...
Other glycan degradation -1.73 1.43e-2 13/18 (72.22%) FUCA1;AGA;MAN2C1;...
Neutrophil extracellular trap formation -1.74 1.38e-2 101/189 (53.44%) MAP3K7;HMGB1;ATG7;...
Pyruvate metabolism -1.74 1.40e-2 41/47 (87.23%) ME1;PDHA1;ADH7;...
Primary bile acid biosynthesis -1.76 1.27e-2 15/17 (88.24%) CYP27A1;ACOX2;ACOT8;...
Peroxisome -1.78 9.82e-3 72/82 (87.8%) EHHADH;PECR;MPV17;...
Glutathione metabolism -1.78 1.05e-2 43/57 (75.44%) ANPEP;GSTM2;GSTM1;...
Lysosome -1.79 1.05e-2 115/128 (89.84%) IDS;SLC11A2;NAGPA;...
Arachidonic acid metabolism -1.80 9.44e-3 48/61 (78.69%) ALOX15;GGT5;CBR3;...
Amino sugar and nucleotide sugar metabolism -1.82 8.24e-3 38/48 (79.17%) UAP1;GNE;PMM2;...
Glycerolipid metabolism -1.85 5.66e-3 44/61 (72.13%) DGKD;LPIN2;AGPAT2;...
Steroid hormone biosynthesis -1.89 3.78e-3 43/61 (70.49%) UGT2B4;CYP21A2;DHRS11;...
Ascorbate and aldarate metabolism -1.90 4.25e-3 15/30 (50%) ALDH2;ALDH3A2;UGDH;...
Pentose and glucuronate interconversions -1.91 4.86e-3 17/34 (50%) AKR1B1;DCXR;UGDH;...
Fatty acid elongation -1.91 5.66e-3 19/27 (70.37%) HADHA;HADHB;ACOT7;...
Glycolysis / Gluconeogenesis -1.95 2.27e-3 56/67 (83.58%) PDHA1;ALDOC;BPGM;...
Propanoate metabolism -1.95 2.83e-3 30/34 (88.24%) ACAT1;EHHADH;ABAT;...
Pentose phosphate pathway -2.02 3.78e-3 25/30 (83.33%) RPIA;PRPS2;PGM1;...
Valine, leucine and isoleucine degradation -2.03 5.66e-3 42/48 (87.5%) ACAT1;EHHADH;HADH;...
Galactose metabolism -2.22 1.13e-2 26/31 (83.87%) AKR1B1;HK1;GALT;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone marrow
Multiple myeloma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U266 CVCL_0566 Homo sapiens 0.125uM - 10uM 6H, 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.125uM - 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.125uM - 10uM 6H, 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.125uM - 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 0.125uM - 10uM 6H, 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.125uM - 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 0.125uM - 10uM 6H, 24H
Peripheral blood
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.125uM - 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.125uM - 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.125uM - 10uM 6H, 24H